422 related articles for article (PubMed ID: 19609520)
21. Biosynthetic gene cluster of the glycopeptide antibiotic teicoplanin: characterization of two glycosyltransferases and the key acyltransferase.
Li TL; Huang F; Haydock SF; Mironenko T; Leadlay PF; Spencer JB
Chem Biol; 2004 Jan; 11(1):107-19. PubMed ID: 15113000
[TBL] [Abstract][Full Text] [Related]
22. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.
Cornaglia G; Rossolini GM
Clin Microbiol Infect; 2009 Mar; 15(3):218-23. PubMed ID: 19335369
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antibacterial activity of alkyl derivatives of the glycopeptide antibiotic A40926 and their amides.
Maffioli SI; Ciabatti R; Romanò G; Marzorati E; Preobrazhenskaya M; Pavlov A
Bioorg Med Chem Lett; 2005 Aug; 15(16):3801-5. PubMed ID: 15993054
[TBL] [Abstract][Full Text] [Related]
24. [Therapy of resistant gram-positive infection: value of glycopeptide antibiotics vancomycin and teicoplanin].
Waldvogel F
Schweiz Med Wochenschr; 1993 Dec; 123(50):2353-6. PubMed ID: 8272810
[No Abstract] [Full Text] [Related]
25. Optimization of culture conditions and scale-up to plant scales for teicoplanin production by Actinoplanes teichomyceticus.
Jung HM; Kim SY; Prabhu P; Moon HJ; Kim IW; Lee JK
Appl Microbiol Biotechnol; 2008 Aug; 80(1):21-7. PubMed ID: 18542948
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of teicoplanin in gram-positive pulmonary infections.
Sanduzzi A; Nani E; Sarno M; Vatrella A; Parrella R; Mattiello A
J Chemother; 1991 Jan; 3 Suppl 1():224-6. PubMed ID: 12041771
[TBL] [Abstract][Full Text] [Related]
27. Actinoplanes teichomyceticus ATCC 31121 as a cell factory for producing teicoplanin.
Taurino C; Frattini L; Marcone GL; Gastaldo L; Marinelli F
Microb Cell Fact; 2011 Oct; 10():82. PubMed ID: 22008254
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of glycopeptide antibiotics.
Finch RG; Eliopoulos GM
J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii5-13. PubMed ID: 15750036
[TBL] [Abstract][Full Text] [Related]
29. Rational selection and engineering of exogenous principal sigma factor (σ(HrdB)) to increase teicoplanin production in an industrial strain of Actinoplanes teichomyceticus.
Wang H; Yang L; Wu K; Li G
Microb Cell Fact; 2014 Jan; 13():10. PubMed ID: 24428890
[TBL] [Abstract][Full Text] [Related]
30. Structure of OxyA tei: completing our picture of the glycopeptide antibiotic producing Cytochrome P450 cascade.
Haslinger K; Cryle MJ
FEBS Lett; 2016 Feb; 590(4):571-81. PubMed ID: 26820384
[TBL] [Abstract][Full Text] [Related]
31. Improved production of teicoplanin using adsorbent resin in fermentations.
Lee JC; Park HR; Park DJ; Lee HB; Kim YB; Kim CJ
Lett Appl Microbiol; 2003; 37(3):196-200. PubMed ID: 12904219
[TBL] [Abstract][Full Text] [Related]
32. Novel teicoplanins by directed biosynthesis.
Lazzarini A; Borghi A; Zerilli LF; Ferrari P; Colombo L; Lancini GC
J Antibiot (Tokyo); 1997 Feb; 50(2):180-3. PubMed ID: 9099232
[No Abstract] [Full Text] [Related]
33. Glycopeptides: Update on an old successful antibiotic class.
Pace JL; Yang G
Biochem Pharmacol; 2006 Mar; 71(7):968-80. PubMed ID: 16412985
[TBL] [Abstract][Full Text] [Related]
34. Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance program.
Jones RN; Sader HS; Fritsche TR; Hogan PA; Sheehan DJ
J Clin Microbiol; 2006 Jul; 44(7):2622-5. PubMed ID: 16825398
[TBL] [Abstract][Full Text] [Related]
35. Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens.
Witte W; Cuny C; Klare I; Nübel U; Strommenger B; Werner G
Int J Med Microbiol; 2008 Jul; 298(5-6):365-77. PubMed ID: 18325835
[TBL] [Abstract][Full Text] [Related]
36. Mannopeptimycins, a novel class of glycopeptide antibiotics active against gram-positive bacteria.
He H
Appl Microbiol Biotechnol; 2005 Jun; 67(4):444-52. PubMed ID: 15702316
[TBL] [Abstract][Full Text] [Related]
37. Fighting infections due to multidrug-resistant Gram-positive pathogens.
Cornaglia G
Clin Microbiol Infect; 2009 Mar; 15(3):209-11. PubMed ID: 19335367
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of dalbavancin against enterococci isolates from wild animals, pets, poultry and humans in Portugal.
Poeta P; Radhouani H; Sargo R; Igrejas G
J Basic Microbiol; 2008 Dec; 48(6):526-8. PubMed ID: 18798175
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities.
Sipos A; Török Z; Rőth E; Kiss-Szikszai A; Batta G; Bereczki I; Fejes Z; Borbás A; Ostorházi E; Rozgonyi F; Naesens L; Herczegh P
Bioorg Med Chem Lett; 2012 Dec; 22(23):7092-6. PubMed ID: 23099097
[TBL] [Abstract][Full Text] [Related]
40. Engineering aspects of beta-lactam biosynthesis.
van den Berg MA; Bovenberg RA; de Laat WT; van Velzen AG
Antonie Van Leeuwenhoek; 1999; 75(1-2):155-61. PubMed ID: 10422588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
